Novo Nordisk And Corbus Pharmaceutical Stocks Plummet - Corbus Pharmaceuticals ( NASDAQ:CRBP ) , Novo Nordisk ( NYSE:NVO )
Shares of Corbus Pharmaceuticals CRBP experienced a severe drop on Friday, plummeting almost 60% from $52 to $21, as competitor Novo Nordisk NVO published trial results for monlunabant, a cannabinoid receptor 1 ( CB1 ) inverse agonist. Novo Nordisk shares also traded down roughly 5.5%
https://www.benzinga.com/markets/cannabis/24/09/40962322/corbus-pharma-crbp-stock-drops-60-after-novo-nordisks-cannabinoid-based-weight-loss-drug-trial-d